Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HEPATITIS B ANTIVIRAL AGENTS
Document Type and Number:
WIPO Patent Application WO/2023/169535
Kind Code:
A1
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit the protein (s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Inventors:
LI WENHUI (CN)
QI XIANGBING (CN)
QIU YAOLING (CN)
LIN MU (CN)
LIU YANG (CN)
SONG XIAO (CN)
TIAN YUBIAO (CN)
LIU HONGLIN (CN)
ZHAO XIAOMIN (CN)
Application Number:
PCT/CN2023/080625
Publication Date:
September 14, 2023
Filing Date:
March 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HUAHUI HEALTH LTD (CN)
International Classes:
C07D471/04; A61K31/416; A61P31/12; C07D401/14
Foreign References:
CN112912142A2021-06-04
US20170217974A12017-08-03
US20160289212A12016-10-06
CN102666537A2012-09-12
Attorney, Agent or Firm:
IPSUNNY (CN)
Download PDF: